NWBOMergers•prnewswire•
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Sentiment:Neutral (60)
Summary
BETHESDA, Md., Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 27, 2025 by prnewswire